Civic Intelligence

Neuropathy Action Foundation

990EZ • Fiscal year 2016 • EIN 20-4792248

Jan 01, 2016 to Dec 31, 2016 • Filed on Apr 27, 2017

Organization Profilewww.neuropathyaction.org
1950 Old Tustin AvenueSanta Ana, CA 92705

(714) 550-9155

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2016

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2016

Net Margin

15th percentile

-22%

Higher net margin than 15% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Top Officer Pay

82nd percentile

$18,000

Higher top officer pay than 82% of similar nonprofits.

Top officer pay equals 17.4% of source-year revenue.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Asset Growth

27th percentile

-11%

Faster asset growth than 27% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Annualized from 2015 to 2016

Revenue Growth

30th percentile

-14%

Faster revenue growth than 30% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Annualized from 2015 to 2016

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Down

$175,120

Down $22,692 (-11%) from 2015

Net Assets

Down

$175,120

Down $22,692 (-11%) from 2015

Liabilities

-

No earlier filing loaded for comparison.

Revenue And Expenses
Liabilities / RevenueScore unavailableNet Margin15th percentile

Revenue

Down

$103,703

Down $16,853 (-14%) from 2015

Expenses

Up

$126,413

Up $11,974 (+10%) from 2015

Net Income

Down

-$22,710

Down $28,827 (-471%) from 2015

Historical Trend

Balance Sheet Trend

Asset Growth27th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400K$300K$200K$100K$0Assets 2011: $187,671Liabilities 2011: $1092011Assets 2012: $247,945Liabilities 2012: $5,7512012Assets 2013: $197,384Liabilities 2013: $02013Assets 2014: $191,695Net Assets 2014: $191,6952014Assets 2015: $197,812Net Assets 2015: $197,8122015Assets 2016: $175,120Net Assets 2016: $175,1202016Assets 2017: $168,885Net Assets 2017: $168,8852017Assets 2018: $179,561Liabilities 2018: $151Net Assets 2018: $179,4102018Assets 2019: $217,122Liabilities 2019: $225Net Assets 2019: $216,8972019Assets 2020: $250,770Liabilities 2020: $92Net Assets 2020: $250,6782020Assets 2021: $287,362Liabilities 2021: $0Net Assets 2021: $287,3622021Assets 2022: $283,966Liabilities 2022: $149Net Assets 2022: $283,8172022Assets 2023: $307,368Liabilities 2023: $402Net Assets 2023: $306,9662023Assets 2024: $347,696Liabilities 2024: $1,909Net Assets 2024: $345,7872024

Highlighted filing

2016

Assets$175,120
Liabilities-
Net Assets$175,120
Open 2016 Filing

Operations Trend

Revenue Growth30th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$150K$100K$50K$0-$50KRevenue 2011: $78,011Expenses 2011: $75,426Net Income 2011: $2,5852011Revenue 2012: $138,538Expenses 2012: $83,906Net Income 2012: $54,6322012Revenue 2013: $102,260Expenses 2013: $147,070Net Income 2013: -$44,8102013Revenue 2014: $99,760Expenses 2014: $105,449Net Income 2014: -$5,6892014Revenue 2015: $120,556Expenses 2015: $114,439Net Income 2015: $6,1172015Revenue 2016: $103,703Expenses 2016: $126,413Net Income 2016: -$22,7102016Revenue 2017: $107,482Expenses 2017: $113,931Net Income 2017: -$6,4492017Revenue 2018: $123,323Expenses 2018: $111,997Net Income 2018: $11,3262018Revenue 2019: $111,900Expenses 2019: $78,948Net Income 2019: $32,9522019Revenue 2020: $116,892Expenses 2020: $83,550Net Income 2020: $33,3422020Revenue 2021: $59,218Expenses 2021: $22,534Net Income 2021: $36,6842021Revenue 2022: $69,500Expenses 2022: $75,326Net Income 2022: -$5,8262022Revenue 2023: $54,886Expenses 2023: $31,603Net Income 2023: $23,2832023Revenue 2024: $73,114Expenses 2024: $34,293Net Income 2024: $38,8212024

Highlighted filing

2016

Revenue$103,703
Expenses$126,413
Net Income-$22,710
Open 2016 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Apr 27, 2017
Return Version
2016v3.0
Gross Receipts
$103,703
Mission and Program Overview

Mission

To educate the general public, healthcare providers, patients and decision makers on what Neuropathy is and to help Neuropathy patients obtain access to individualized treatments.

Program Services

DescriptionGrantsExpenses
The NAF celebrated its 10 year anniversary in 2016. Therefore, the NAF held its 10th annual "Neuropathy Action Awareness Day" which provided an opportunity for patients to interact with other patients, physicians and exhibitors. Over 200 Neuropathy patients/caretakers attended this event in person and over 1,000 watched the event live via the latest live streaming technology to learn about neuropathy and to promote awareness of this disease. The NAF has accomplished more than we ever imagined possible since our inception. A few of the NAF's accomplishments include:Provided comprehensive online neuropathy resources that have been viewed by millions of neuropathy patients and their caregivers from around the world annually.Provided patients with our bi-monthly "Patient Voice" e-newsletter.Helped over 532 patients with access issues obtaining IVIG and other medications.Held the largest neuropathy education event in the U.S. annually called the "Neuropathy Action Awareness Day." For the past ten years thousands have attended in person and thousands more have watched on the NAF website.Created a Diabetic Peripheral Neuropathy (DPN) public service announcement (PSA) featuring celebrity Jerry Mathers from the classic hit sitcom Leave it to Beaver. The PSA has aired in 39 cities in 23 states.Created the first ever multifocal motor neuropathy (MMN) brochure and PSA. The PSA has aired in 74 cities in 30 states and has received over 15,000 views on YouTube.Featured on ABC, NBC, CNN, IG Living, Neurology Now and many other publications and broadcasts bringing increased awareness to neuropathy.Advocated for access to IVIG and other medications via press conferences, letters, newsletter articles and traditional and social media$75,890-
Through our website and patient brochures in 2016 the NAF reached millions of patients and interested parties obtain the necessary resources, information and tools to access individualized treatment to improve their quality of life. The NAF also increased awareness among physicians, appropriate institutions, the general public and public policy officials that neuropathy can potentially be a serious, widespread and disabling condition, which may be treatable when appropriate medical care is provided. Other 2016 accomplishments include:In 2016 the NAF launched a Diabetic Peripheral Neuropathy (DPN) national survey. DPN is the most common type of neuropathy in the United States causing pain or loss of sensation in the feet, hands and arms. It is estimated that there are 15-20 million cases in the United States alone. Given the size of this problem, it is odd that more people do not know about it. Therefore, the NAF launched a DPN Quality of Life (QOL) Survey in 2016. By examining the QOL of DPN patients the NAF hopes to increase disease awareness among researchers, providers, the general public and public policy officials. Understanding QOL is critical to better understand what is needed to help DPN patients.In 2016 the NAF announced the results from the first ever international Multifocal Motor Neuropathy (MMN) Quality of Life (QOL) Patient Survey. The survey focused on three primary areas: timely and accurate diagnosis, efficacy of treatment, and the impact of the disease on patients quality of life. The majority of the 214 patients completing the survey were from the United States (71.15%) and the United Kingdom (6.73%) with respondents from 22 other countries also contributing to the results. While the majority of patients reported that they were diagnosed between the ages of 41 and 65 years (56.52%), more than 67% of those completing the survey reported that it took more than one year to be diagnosed. Of these individuals, more than 44% reported that it took 2-3 years or longer to be accurately diagnosed. The majority of the misdiagnoses were reported by Neurologists (54.60%) and Family Care Providers (20.69%). The data also showed that 51.96% of the respondents had conduction block, a characteristic finding of the condition. When asked about treatment options, 91.43% reported receiving intravenous immunoglobulin (IVIg) and 8.57% reported receiving subcutaneous immunoglobulin (SCIg) therapy. A reduction in symptoms was reported within one week of their first Ig treatment by 36.30% of respondents. Only 6.67% reported that IG did not help them manage their symptoms. If recommended by their Neurologist, 81.05% would consider SCIg treatment. Half of all participants in the survey stated that MMN often or always interferes with their employment and 56% said it impacts their overall quality of life. Basic tasks such as turning a key in a lock are either difficult or impossible for 53.24% of the MMN patients participating in this assessment. The data showed that 61.19% were either unable or had difficulty buttoning a shirt, though 61.62% are able to shop and run errands by themselves. While 58.38% of survey participants said that they had difficulty falling asleep at night due to MMN, 77.66% reported daytime sleepiness. A more detailed analysis of the survey findings is available on the NAF website at http://www.neuropathyaction.org/downloads/MMN_article%XXX-XX-XXXX.pdf--
Compensation and Service Providers
Top Officer Pay82nd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Dominick V SpataforaPresidentPT$18,000-$18,000
Astrid G Meghrigian JDDirector-$0--
James D Lee JDDirector-$0--
Dustin CorcoranDirector-$0--
Leslie Macgregor LevineDirector-$0--
Jeffrey W Ralph MDDirector-$0--
Richard S Zimmerman MDDirector-$0--
Kathleen S CreasonTreasurer-$0--
Filing and Contact Details

Filer

Filer Name
Neuropathy Action Foundation
EIN
20-4792248
Phone
7145509155
Address
1950 Old Tustin Avenue, Santa Ana, CA 92705

Signing Officer

Name
Christopher DeSantis
Title
Executive Director
Signed
2017-04-27
Discuss with paid preparer
Yes

Preparer

Firm
Russell CPAs
Address
1337 Howe Ave Ste 265, Sacramento, CA 95825-3361
Preparer
Jason Russell CPA
Phone
9169669366
Supplemental Narrative

Additional Explanations

Other Expenses.1002

“Office Expenses $69”

Other Expenses.1005

“Travel $224”

Other Expenses.1007

“Conferences, Conventions, and Meetings $37526”

Other Expenses.1012

“Insurance $1050”

Other Expenses.1

“Patient Education/Awareness $18194”

Other Expenses.2

“MMN Survey $11178”

Other Expenses.3

“Promotion and Marketing $6621”

Other Expenses.4

“Audio Visual Services $2996”

Other Expenses.5

“Staffing $2476”

Other Expenses.6

“Board Meetings $1914”

Other Expenses.7

“Internet Services $1452”

Other Expenses.8

“Website Maint & Services $1359”

Other Expenses.9

“Office Expenses $1269”

Other Expenses.10

“Travel Scholarships $1237”

Other Expenses.11

“Award and Prizes $1089”

Other Expenses.14

“Convention Supplies $438”

Other Expenses.15

“Credit Card Processing $396”

Other Expenses.16

“Bank Charges $330”

Other Expenses.17

“Utilities $272”

Other Expenses.18

“Dues & Subscriptions $250”

Other Expenses.19

“Supplies $220”

Other Expenses.20

“Taxes & License $124”

Other Expenses.21

“DPN Survey $78”

Raw XML Appendix226 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0Medical Association Management
IRS990EZ/BooksInCareOfDetail/PhoneNum07145509155
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01950 Old Tustin Ave
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Santa Ana
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092705
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0197812
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0175120
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt072437
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-22710
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt015908
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form720FiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0197812
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0175120
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt0103703
IRS990EZ/GrossReceiptsForPublicUseAmt00
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InitiationFeesAndCapContriAmt00
IRS990EZ/InvestmentIncomeAmt051
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0197812
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0175120
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0197812
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0175120
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt011.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt50.70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt60.23
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt70.23
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt018000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Dominick V Spatafora
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Astrid G Meghrigian JD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2James D Lee JD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Dustin Corcoran
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Leslie Macgregor Levine
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5Jeffrey W Ralph MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6Richard S Zimmerman MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7Kathleen S Creason
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7Treasurer
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationFiled990TInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherChangesInNetAssetsAmt018
IRS990EZ/OtherExpensesTotalAmt090762
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0To educate the general public, healthcare providers, patients and decision makers on what Neuropathy is and to help Neuropathy patients obtain access to individualized treatments.
IRS990EZ/PrintingPublicationsPostageAmt01743
IRS990EZ/ProgramServiceRevenueAmt031215
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0The NAF celebrated its 10 year anniversary in 2016. Therefore, the NAF held its 10th annual "Neuropathy Action Awareness Day" which provided an opportunity for patients to interact with other patients, physicians and exhibitors. Over 200 Neuropathy patients/caretakers attended this event in person and over 1,000 watched the event live via the latest live streaming technology to learn about neuropathy and to promote awareness of this disease. The NAF has accomplished more than we ever imagined possible since our inception. A few of the NAF's accomplishments include:Provided comprehensive online neuropathy resources that have been viewed by millions of neuropathy patients and their caregivers from around the world annually.Provided patients with our bi-monthly "Patient Voice" e-newsletter.Helped over 532 patients with access issues obtaining IVIG and other medications.Held the largest neuropathy education event in the U.S. annually called the "Neuropathy Action Awareness Day." For the past ten years thousands have attended in person and thousands more have watched on the NAF website.Created a Diabetic Peripheral Neuropathy (DPN) public service announcement (PSA) featuring celebrity Jerry Mathers from the classic hit sitcom Leave it to Beaver. The PSA has aired in 39 cities in 23 states.Created the first ever multifocal motor neuropathy (MMN) brochure and PSA. The PSA has aired in 74 cities in 30 states and has received over 15,000 views on YouTube.Featured on ABC, NBC, CNN, IG Living, Neurology Now and many other publications and broadcasts bringing increased awareness to neuropathy.Advocated for access to IVIG and other medications via press conferences, letters, newsletter articles and traditional and social media
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1Through our website and patient brochures in 2016 the NAF reached millions of patients and interested parties obtain the necessary resources, information and tools to access individualized treatment to improve their quality of life. The NAF also increased awareness among physicians, appropriate institutions, the general public and public policy officials that neuropathy can potentially be a serious, widespread and disabling condition, which may be treatable when appropriate medical care is provided. Other 2016 accomplishments include:In 2016 the NAF launched a Diabetic Peripheral Neuropathy (DPN) national survey. DPN is the most common type of neuropathy in the United States causing pain or loss of sensation in the feet, hands and arms. It is estimated that there are 15-20 million cases in the United States alone. Given the size of this problem, it is odd that more people do not know about it. Therefore, the NAF launched a DPN Quality of Life (QOL) Survey in 2016. By examining the QOL of DPN patients the NAF hopes to increase disease awareness among researchers, providers, the general public and public policy officials. Understanding QOL is critical to better understand what is needed to help DPN patients.In 2016 the NAF announced the results from the first ever international Multifocal Motor Neuropathy (MMN) Quality of Life (QOL) Patient Survey. The survey focused on three primary areas: timely and accurate diagnosis, efficacy of treatment, and the impact of the disease on patients quality of life. The majority of the 214 patients completing the survey were from the United States (71.15%) and the United Kingdom (6.73%) with respondents from 22 other countries also contributing to the results. While the majority of patients reported that they were diagnosed between the ages of 41 and 65 years (56.52%), more than 67% of those completing the survey reported that it took more than one year to be diagnosed. Of these individuals, more than 44% reported that it took 2-3 years or longer to be accurately diagnosed. The majority of the misdiagnoses were reported by Neurologists (54.60%) and Family Care Providers (20.69%). The data also showed that 51.96% of the respondents had conduction block, a characteristic finding of the condition. When asked about treatment options, 91.43% reported receiving intravenous immunoglobulin (IVIg) and 8.57% reported receiving subcutaneous immunoglobulin (SCIg) therapy. A reduction in symptoms was reported within one week of their first Ig treatment by 36.30% of respondents. Only 6.67% reported that IG did not help them manage their symptoms. If recommended by their Neurologist, 81.05% would consider SCIg treatment. Half of all participants in the survey stated that MMN often or always interferes with their employment and 56% said it impacts their overall quality of life. Basic tasks such as turning a key in a lock are either difficult or impossible for 53.24% of the MMN patients participating in this assessment. The data showed that 61.19% were either unable or had difficulty buttoning a shirt, though 61.62% are able to shop and run errands by themselves. While 58.38% of survey participants said that they had difficulty falling asleep at night due to MMN, 77.66% reported daytime sleepiness. A more detailed analysis of the survey findings is available on the NAF website at http://www.neuropathyaction.org/downloads/MMN_article%XXX-XX-XXXX.pdf
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt075890
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/RelatedOrgSect527OrgInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt018000
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0126413
IRS990EZ/TotalProgramServiceExpensesAmt075890
IRS990EZ/TotalRevenueAmt0103703
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/WebsiteAddressTxt0www.neuropathyaction.org
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt072437
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt072126
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt079890
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt090301
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt0131087
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0445841
IRS990ScheduleA/GovtFurnSrvcFcltsVl509Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt051
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt070
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt037
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt0104
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt0266
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt0528
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt00
IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/TotalAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt051
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt070
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt037
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt0104
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt0266
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt0528
IRS990ScheduleA/InvestmentIncomeCYPct00.00120
IRS990ScheduleA/InvestmentIncomePYPct00.00120
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt00
IRS990ScheduleA/OtherIncome509Grp/TotalAmt00
IRS990ScheduleA/Post1975UBTIGrp/TotalAmt00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99880
IRS990ScheduleA/PublicSupportPY509Pct00.99880
IRS990ScheduleA/PublicSupportTotal509Amt0445841
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft509Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt072437
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt072126
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt079890
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt090301
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0131087
IRS990ScheduleA/Total509Grp/TotalAmt0445841
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt072488
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt072196
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt079927
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt090405
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0131353
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0446369
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Office Expenses $69
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Travel $224
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Conferences, Conventions, and Meetings $37526
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3Insurance $1050
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4Patient Education/Awareness $18194
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5MMN Survey $11178
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6Promotion and Marketing $6621
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7Audio Visual Services $2996
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt8Staffing $2476
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt9Board Meetings $1914
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt10Internet Services $1452
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt11Website Maint & Services $1359
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt12Office Expenses $1269
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt13Travel Scholarships $1237
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt14Award and Prizes $1089
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt15Convention Supplies $438
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt16Credit Card Processing $396
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt17Bank Charges $330
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt18Utilities $272
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt19Dues & Subscriptions $250
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt20Supplies $220
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt21Taxes & License $124
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt22DPN Survey $78
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.1005
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1007
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.1012
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7Other Expenses.4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc8Other Expenses.5
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc9Other Expenses.6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc10Other Expenses.7
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc11Other Expenses.8
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc12Other Expenses.9
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc13Other Expenses.10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc14Other Expenses.11
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc15Other Expenses.14
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc16Other Expenses.15
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc17Other Expenses.16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc18Other Expenses.17
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc19Other Expenses.18
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc20Other Expenses.19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc21Other Expenses.20
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc22Other Expenses.21
ReturnHeader/BuildTS02017-02-10 21:41:12Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0Christopher DeSantis
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Executive Director
ReturnHeader/BusinessOfficerGrp/SignatureDt02017-04-27
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0Neuropathy Action Foundation
ReturnHeader/Filer/BusinessNameControlTxt0NEUR
ReturnHeader/Filer/EIN0204792248
ReturnHeader/Filer/PhoneNum07145509155
ReturnHeader/Filer/USAddress/AddressLine1Txt01950 Old Tustin Avenue
ReturnHeader/Filer/USAddress/CityNm0Santa Ana
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092705
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Russell CPAs
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt01337 Howe Ave Ste 265
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Sacramento
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0958253361
ReturnHeader/PreparerPersonGrp/PhoneNum09169669366
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0Jason Russell CPA
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02017-04-27T14:54:55-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02016-01-01
ReturnHeader/TaxPeriodEndDt02016-12-31
ReturnHeader/TaxYr02016

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2016 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$175,120
Liabilities
-
Net assets
$175,120
Revenue
$103,703
Expenses
$126,413
Net income
-$22,710
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$3.48$0.02$3.46$0.73$0.34$0.39
2023Detailed filing. Detailed filing data is available for this year.$3.07$0.00$3.07$0.55$0.32$0.23
2022Detailed filing. Detailed filing data is available for this year.$2.84$0.00$2.84$0.70$0.75$0.06
2021Detailed filing. Detailed filing data is available for this year.$2.87$0.00$2.87$0.59$0.23$0.37
2020Detailed filing. Detailed filing data is available for this year.$2.51$0.00$2.51$1.17$0.84$0.33
2019Detailed filing. Detailed filing data is available for this year.$2.17$0.00$2.17$1.12$0.79$0.33
2018Detailed filing. Detailed filing data is available for this year.$1.80$0.00$1.79$1.23$1.12$0.11
2017Detailed filing. Detailed filing data is available for this year.$1.69$1.69$1.07$1.14$0.06
2016Detailed filing. Detailed filing data is available for this year.$1.75$1.75$1.04$1.26$0.23
2015Detailed filing. Detailed filing data is available for this year.$1.98$1.98$1.21$1.14$0.06
2014Detailed filing. Detailed filing data is available for this year.$1.92$1.92$1.00$1.05$0.06
2013Summary only. Only limited summary data is available for this year.$1.97$0.00$1.02$1.47$0.45
2012Summary only. Only limited summary data is available for this year.$2.48$0.06$1.39$0.84$0.55
2011Summary only. Only limited summary data is available for this year.$1.88$0.00$0.78$0.75$0.03